ARCHIVES

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

This article is from The Cancer Letter archive.

Vol. 09 No. 23 | June 10, 1983

Download PDF Visit The Full Archive

Related Articles

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

September 25, 1998

One In 8 Survivors Report Suicidal Thoughts, Attempts

August 25, 2006

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996